Bobbie 6:15 am on Friday, January 6, 2017

REGN dumping

Jeff 6:16 am on Friday, January 6, 2017

AMGN eating their lunch.

http://finance.yahoo.com/news/amgens-repatha-wins-over-sanofi-124512784.html
geewhiz112 7:29 am on Friday, January 6, 2017

But $LABU is up over 5%. $REGN quite an outlier.
- fuzzballl 7:35 am on Friday, January 6, 2017
  
  I thought this verdict was out yesterday or the day before. Surprised the market is reacting this bad today. Appeals still to go and how big is this particular drug to REGN’s business anyway? All my short strikes are safe so far. If REGN doesn’t recover much before earnings we may have a nice opportunity for selling WAY out of the money puts then.
  
  From Jeff’s link…
  
  “We note that both Repatha and Praluent are used to inhibit a protein known as PCSK9, which lowers the liver’s ability to remove “bad” cholesterol (LDL-C) from the blood. While both the drugs hit the markets in 2015 within a month, the companies have been working rigorously on securing deals with health insurers and pharmacy benefit managers. However, sales of the drugs have been below expectations since launch due to pricing and reimbursement issues.”
  - fuzzballl 11:40 am on Friday, January 6, 2017
    
    http://blogs.barrons.com/stockstowatchtoday/2017/01/06/regeneron-lets-make-a-deal/